#USA #Bainbridge Island #Solius Labs #Solius Pro #UVB Therapy

Solius Labs Shines Bright in Fast Company’s 2026 Tech Awards

On October 7, 2026, Solius Labs, the world’s sole provider of personalized sunlight solutions, received significant recognition from Fast Company by having its innovative product, Solius Pro, listed among the ‘Next Big Things in Tech’ in the Wellness and Fitness category. This prestigious acknowledgment highlights the potential of breakthrough technologies that are set to transform industries and improve lives across the globe.

The Solius Pro is celebrated for being the first FDA-cleared over-the-counter personalized UVB light therapy device. It is designed to deliver the benefits of sunlight in a convenient and safe manner. With a unique skin analysis system that tailors the UVB exposure to individual skin tones, users can enjoy the advantages of sunlight while minimizing harmful UV exposure by an impressive 99% compared to natural sunlight.

A New Era in UVB Light Therapy

The technology behind the Solius Pro allows individuals to receive the equivalent benefits of natural sunlight in just about five minutes per week. In clinical trials, users reported a significant increase in serum vitamin D levels, averaging a rise of 76% (10.2 ng/mL), showcasing the device's effective contribution to enhancing users' health.

But the advantages of the Solius Pro stretch beyond merely boosting vitamin D. A wealth of recent research establishes a connection between UVB exposure and numerous bodily functions such as bone health, immune system strength, mood regulation, hormonal balance, and the gut microbiome. This device has been meticulously engineered to facilitate safe UVB light therapy all year round, catering to the health needs of every individual.

Vision of Health Optimized

Chris Kiple, the CEO of Solius Labs, expressed enthusiasm over the recognition, stating, "Being named to Fast Company’s Next Big Things in Tech validates what we set out to build - a way to deliver the benefits of sunlight personalized to your skin tone and needs, backed by clinical evidence and cleared by the FDA."

Kiple further emphasized that Solius Pro marks the advent of a groundbreaking category of medical devices engineered to optimize health and longevity. He believes that sunlight is a fundamental component for overall wellness and is thrilled to widen access to the clinical benefits of light medicine through personalized solutions.

The Future Ahead

The Next Big Things in Tech initiative by Fast Company showcases innovative technologies from various sectors, including startups and research groups, all on track to make impactful advancements in consumer, business, and social spheres in the coming years. The honorees across this category demonstrate that each innovation possesses the potential to create significant changes in the near future.

About Solius Labs

Founded on principles of innovation and wellness, Solius Labs is recognized as the first Personalized Sunlight company in the world, developing FDA-cleared, medical-grade UVB light therapy technologies. These technologies are designed to safely mimic the biological advantages associated with sunlight exposure year-round. By combining a targeted UVB spectrum with personalized dosing and clinical validation, Solius Labs is on a mission to revolutionize how UVB light therapy supports human health.

For more information on their pioneering products, visit Solius.com.

About Fast Company

Fast Company stands as a leading media platform committed to the intersections of business, design, and innovation. It engages influential leaders and companies while addressing the future of business. The brand is headquartered in New York City and is published under Mansueto Ventures LLC, alongside its companion publication Inc. For more insights, check out fastcompany.com.